Ronald C Chen MD
Professor and Chair, University of Kansas, Kansas City, KS
Join to View Full Profile
4001 Rainbow BlvdStop 4033Kansas City, KS 66160
Phone+1 913-588-3600
Fax+1 913-588-3663
Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ronald Chen is a radiation oncologist in Kansas City, KS. He received his medical degree from Harvard Medical School and has been in practice 13 years. He is experienced in brachytherapy, prostate cancer, stereotactic radiosurgery, intensity-modulated radiation therapy, and radiosurgery.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2005 - 2009
Mass General Brigham/Massachusetts General HospitalInternship, Internal Medicine, 2004 - 2005
Harvard Medical SchoolClass of 2004
Certifications & Licensure
NM State Medical License 2023 - 2027
IA State Medical License 2023 - 2026
MO State Medical License 2019 - 2026
NE State Medical License 2023 - 2026
CO State Medical License 2022 - 2025
KS State Medical License 2019 - 2025
NC State Medical License 2009 - 2020
American Board of Radiology Radiation Oncology- Join now to see all
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy Start of enrollment: 2012 Jun 01
- Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer Start of enrollment: 2013 Oct 01
- Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer Patients Start of enrollment: 2017 May 08
- Join now to see all
Publications & Presentations
PubMed
- Treatment switching between Enzalutamide and Abiraterone Acetate and time to oral opioid initiation in castration-resistant prostate cancer patients.Ibrahim M Asiri, Ronald C Chen, Viraj Master, Lanyu Mi, Sarah E James
Cancer Epidemiology. 2025-04-01 - Feasibility of Pay for Performance and Transparency Interventions on the Selection and Quality of Observational Management for Patients With Low-Risk Prostate Cancer i...Franklin D Gaylis, Michael S Leapman, Shellie D Ellis, Steven Hu, Matthew R Cooperberg
Urology Practice. 2025-03-01 - Real-world survival and economic burden among patients with locally advanced or metastatic urothelial carcinoma in the United States.Ronald C Chen, Rupali Fuldeore, Alexandra Greatsinger, Zsolt Hepp, Qing Liu
Urologic Oncology. 2025-03-01
Lectures
- Health Services Research, Clinical Informatics, and Quality of CareASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- Quality-adjusted time without symptoms or toxicity (Q-TWiST): Analysis of cabozantinib (Cabo) vs sunitinib (Sun) in patients with advanced renal cell carcinoma (aRCC) ...2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- Frequency of post-treatment surveillance and survival in localized prostate cancer: AFT-30 a national study.2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
Press Mentions
KU Cancer Center Uses Art to Reach Underprivileged CommunitiesFebruary 22nd, 2023- KU Cancer Center Uses Art to Reach Underserved CommunitiesFebruary 21st, 2023
- NRG Oncology Trial Aimed to Improve Prostate Cancer Survivor Care Planning Reaches Accrual GoalJuly 29th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
